| Natural history of progression after PSA elevation following radical prostatectomy CR Pound, AW Partin, MA Eisenberger, DW Chan, JD Pearson, PC Walsh Jama 281 (17), 1591-1597, 1999 | 3764 | 1999 |
| The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer AW Partin, J Yoo, HB Carter, JD Pearson, DW Chan, JI Epstein, PC Walsh The Journal of urology 150 (1), 110-114, 1993 | 1629 | 1993 |
| Longitudinal evaluation of prostate-specific antigen levels in men with and without prostate disease HB Carter, JD Pearson, EJ Metter, LJ Brant, DW Chan, R Andres, ... Jama 267 (16), 2215-2220, 1992 | 1626 | 1992 |
| Proteomics and bioinformatics approaches for identification of serum biomarkers to detect breast cancer J Li, Z Zhang, J Rosenzweig, YY Wang, DW Chan Clinical chemistry 48 (8), 1296-1304, 2002 | 1394 | 2002 |
| Three biomarkers identified from serum proteomic analysis for the detection of early stage ovarian cancer Z Zhang, RC Bast Jr, Y Yu, J Li, LJ Sokoll, AJ Rai, JM Rosenzweig, ... Cancer research 64 (16), 5882-5890, 2004 | 1317 | 2004 |
| Immunosensors—principles and applications to clinical chemistry PB Luppa, LJ Sokoll, DW Chan Clinica chimica acta 314 (1-2), 1-26, 2001 | 1030 | 2001 |
| Overview of the HUPO Plasma Proteome Project: results from the pilot phase with 35 collaborating laboratories and multiple analytical groups, generating a core dataset of 3020 … GS Omenn, DJ States, M Adamski, TW Blackwell, R Menon, H Hermjakob, ... Proteomics 5 (13), 3226-3245, 2005 | 938 | 2005 |
| Integrated proteogenomic characterization of human high-grade serous ovarian cancer H Zhang, T Liu, Z Zhang, SH Payne, B Zhang, JE McDermott, JY Zhou, ... Cell 166 (3), 755-765, 2016 | 909 | 2016 |
| Prostate specific antigen in the staging of localized prostate cancer: influence of tumor differentiation, tumor volume and benign hyperplasia AW Partin, HB Carter, DW Chan, JI Epstein, JE Oesterling, RC Rock, ... The Journal of urology 143 (4), 747-752, 1990 | 875 | 1990 |
| National Academy of Clinical Biochemistry laboratory medicine practice guidelines for use of tumor markers in testicular, prostate, colorectal, breast, and ovarian cancers CM Sturgeon, MJ Duffy, UH Stenman, H Lilja, N Brunner, DW Chan, ... Clinical chemistry 54 (12), e11-e79, 2008 | 847* | 2008 |
| Standard operating procedures for serum and plasma collection: early detection research network consensus statement standard operating procedure integration working group MK Tuck, DW Chan, D Chia, AK Godwin, WE Grizzle, KE Krueger, W Rom, ... Journal of proteome research 8 (1), 113-117, 2009 | 803 | 2009 |
| Prostate specific antigen in the preoperative and postoperative evaluation of localized prostatic cancer treated with radical prostatectomy JE Oesterling, DW Chan, JI Epstein, AW Kimball Jr, DJ Bruzek, RC Rock, ... The Journal of urology 139 (4), 766-772, 1988 | 727 | 1988 |
| HUPO Plasma Proteome Project specimen collection and handling: towards the standardization of parameters for plasma proteome samples AJ Rai, CA Gelfand, BC Haywood, DJ Warunek, J Yi, MD Schuchard, ... Proteomics 5 (13), 3262-3277, 2005 | 616 | 2005 |
| A multicenter study of [-2] pro-prostate specific antigen combined with prostate specific antigen and free prostate specific antigen for prostate cancer detection in the 2.0 to … WJ Catalona, AW Partin, MG Sanda, JT Wei, GG Klee, CH Bangma, ... The Journal of urology 185 (5), 1650-1655, 2011 | 600 | 2011 |
| Proteogenomic analysis of human colon cancer reveals new therapeutic opportunities S Vasaikar, C Huang, X Wang, VA Petyuk, SR Savage, B Wen, Y Dou, ... Cell 177 (4), 1035-1049. e19, 2019 | 581 | 2019 |
| Targeted peptide measurements in biology and medicine: best practices for mass spectrometry-based assay development using a fit-for-purpose approach SA Carr, SE Abbatiello, BL Ackermann, C Borchers, B Domon, ... Molecular & Cellular Proteomics 13 (3), 907-917, 2014 | 563 | 2014 |
| Multi-laboratory assessment of reproducibility, qualitative and quantitative performance of SWATH-mass spectrometry BC Collins, CL Hunter, Y Liu, B Schilling, G Rosenberger, SL Bader, ... Nature communications 8 (1), 291, 2017 | 515 | 2017 |
| Identification of hepatocarcinoma-intestine-pancreas/pancreatitis-associated protein I as a biomarker for pancreatic ductal adenocarcinoma by protein biochip technology C Rosty, L Christa, S Kuzdzal, WM Baldwin, ML Zahurak, F Carnot, ... Cancer research 62 (6), 1868-1875, 2002 | 509 | 2002 |
| Translation of proteomic biomarkers into FDA approved cancer diagnostics: issues and challenges AK Füzéry, J Levin, MM Chan, DW Chan Clinical proteomics 10, 1-14, 2013 | 504 | 2013 |
| Proteogenomic characterization reveals therapeutic vulnerabilities in lung adenocarcinoma MA Gillette, S Satpathy, S Cao, SM Dhanasekaran, SV Vasaikar, K Krug, ... Cell 182 (1), 200-225. e35, 2020 | 479 | 2020 |
